Tin tức thị trường chứng khoán
Tin tức tài chính mới nhất · Cập Nhật Tháng 7 28, 2026
Đằng sau kết quả kinh doanh quý I vượt trội của Big Oil: Sự trỗi dậy thầm lặng của các bàn giao dịch
Behind Big Oil’s first-quarter beat: The quiet rise of trading desks
The panel is divided on the sustainability and value of European majors' trading desks. While some see it as a …
Cổ phiếu Palantir rẻ hơn Alphabet theo thước đo định giá này
Palantir stock is cheaper than Alphabet on this valuation metric
The panel consensus is bearish on Palantir, citing high valuation multiples, FCF volatility, and execution risks in transitioning to a …
$7 Tỷ Đặt Cược Dầu Đúng Thời Điểm Gây Lo Ngại Giao Dịch Nội Gián
$7 Billion In Perfectly Timed Oil Bets Sparks Insider Trading Fears
The panel discussed large-scale trades in energy futures that preceded geopolitical announcements, with some suggesting insider trading or market manipulation. …
Citi Giữ Quan Điểm Bóng Đá Về Veradermics, Incorporated (MANE)
Citi Remains Bullish on Veradermics, Incorporated (MANE)
The panel is divided on MANE's potential. While some see promise in its Phase 2/3 Part A data and the …
Ripple (XRP) Đã Chốt 10 Thỏa Thuận Lớn Trong Năm Nay: Đây Là Bảng Điểm Cho Từng Quan Hệ Đối Tác
Ripple (XRP) Has Closed 10 Major Deals This Year: Here’s the Scoreboard for Each Partnership
Despite Ripple's infrastructure wins, XRP's price performance remains lackluster due to regulatory uncertainty and limited token utility. The market is …
JPMorgan Khuyến nghị Mua Cổ phiếu Erasca (ERAS) ở Mức Hiện Tại
JPMorgan Recommends Buying Erasca (ERAS) Stock at Current Levels
The panel consensus is bearish on Erasca (ERAS), with concerns around 'not fully clean' Phase 1 data, safety caveats, and …
Stifel Vẫn Lạc Quan Về Tango Therapeutics (TNGX)
Stifel Remains Bullish on Tango Therapeutics (TNGX)
The panel's discussion on TNGX revolves around the potential of its PRMT5/RAS(ON) combo in pancreatic cancer, with a cash runway …
Leerink Partners Nâng Giá Mục Tiêu Cổ Phiếu Oruka Therapeutics, Inc. (ORKA)
Leerink Partners Lifts PT on Oruka Therapeutics, Inc. (ORKA)
ORKA-001's Phase 2a results are impressive, but its path to market is uncertain due to manufacturing challenges, competition, and commercial …
AnaptysBio (ANAB) Có Phải Là Một Trong Những Cổ Phiếu Chăm Sóc Sức Khỏe Hoạt Động Tốt Nhất Tính Đến Nay Năm 2026?
Is AnaptysBio (ANAB) One of the Best Performing Healthcare Stocks so Far in 2026?
The panel is divided on ANAB's spinoff of TRAX, with some seeing it as a value-enhancing move that separates stable …
Revolution Medicines (RVMD) Nhận Thư "An Toàn Để Tiếp Tục" Từ FDA Cho Daraxonrasib
Revolution Medicines (RVMD) Receives FDA’s “Safe to Proceed” Letter for Daraxonrasib
The panel is mixed on RVMD's 'safe to proceed' EAP, with concerns about the lack of efficacy data, manufacturing challenges, …
RBC Capital Nâng PT cho Acadia Healthcare Company (ACHC) Sau Khi Vượt Kì Vọng Lợi Nhuận Q1
RBC Capital Lifts PT on Acadia Healthcare Company (ACHC) Following Q1 Earnings Beat
While ACHC's Q1 earnings beat and upgrades suggest potential for EBITDA improvement and a 'harvest' from underperforming facilities, the consensus …
Twist Bioscience Corporation (TWST) Công Bố Kết Quả Tài Chính Quý 2 Năm 2026
Twist Bioscience Corporation (TWST) Announces Q2 2026 Financial Results
The panelists agree that Twist Bioscience has shown operational momentum with 13 consecutive quarters of growth and a 19% YoY …